Qiagen, NL0012169213

Qiagen Stock - weekly outlook with earnings ahead

Published on 06/22/2026 at 13:03 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Qiagen stock starts the week without fresh ad-hoc headlines, so investors are orienting themselves by the upcoming earnings timetable and existing analyst consensus. The focus is on when the next results drop and how the market is currently valuing the diagnostics group.

Qiagen, NL0012169213, Illustration mit AI erstellt.
Qiagen, NL0012169213, Illustration mit AI erstellt.

Edited by ad hoc news Earnings & Calendar Desk. Verified prior to publication on 06/22/2026, 13:02 CET. Details in the imprint.

Qiagen (NL0012169213) begins the new week without a fresh market-moving corporate release, so the focus for many investors shifts to the upcoming earnings timetable and existing analyst expectations. According to recent market data, consensus still reflects cautious optimism on the diagnostics specialist.

Go deeper

All news and data on Qiagen stock

Key figures, corporate news and regulatory filings on Qiagen stock are bundled on the ad hoc news topic page and the company’s own investor-relations site.

What recent data show

An earlier overview from ad hoc news put the most recent available Xetra close for Qiagen stock at EUR 32.14 on 06/19/2026 at 17:35 CET, implying a market value of roughly EUR 7.0 billion at that time.

On the US market, the New York-listed Qiagen shares under ticker QGEN most recently closed at about $37.00 on 06/18/2026, according to market data services that track the Standard & Poor's 500 index universe and broader health-care peer group.

Weekly outlook and earnings focus

With no new ad-hoc statement on the tape, attention turns to the company’s financial calendar as published on its investor-relations pages, which typically flag upcoming quarterly reports, conference calls and capital-market events for Qiagen.

So far, the next earnings date for Qiagen has not been officially fixed in public exchange data sets, which leaves investors dependent on recurring calendar updates from the company and on analyst models that extrapolate normal reporting rhythms.

What the company sells

Qiagen’s business centers on sample-to-insight molecular testing solutions, spanning consumables and instruments used to extract, purify and analyze DNA, RNA and proteins for diagnostics, pharmaceutical research and academic laboratories worldwide.

Where the stock trades today

The shares of Qiagen (NL0012169213) trade on Xetra at EUR 32.14 as of 06/19/2026, 17:35 CET.

Key facts on Qiagen stock

  • Company: QIAGEN N.V.
  • ISIN: NL0012169213
  • WKN: A2DKCH
  • Ticker: QIA
  • Venue: Xetra
  • Price (as of 06/19/2026, 17:35 CET): 32.14 EUR
  • Market cap: 7,000,000,000 EUR (as of 06/19/2026, rounded)
  • Sector / Industry: Health Care - Life Sciences Tools & Services
  • Index membership: MDAX, TecDAX, Stoxx Europe 600
  • Next earnings date: not officially scheduled

More on Qiagen stock on social media

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | NL0012169213 | QIAGEN | boerse | 69602362 | bgmi